InvestorsHub Logo
Followers 21
Posts 980
Boards Moderated 0
Alias Born 03/20/2019

Re: None

Saturday, 10/10/2020 7:09:05 PM

Saturday, October 10, 2020 7:09:05 PM

Post# of 426487
The Supreme Court has a high opinion of Judge Newman. I'm sure she wrote her opinion in the Teva case so it could withstand further judicial scrutiny and be upheld. You can't argue facts afresh at the appellate level. She called this out in her ruling. Even if en banc is granted, her ruling could still prevail. Moreover, the Supreme Court could see things the way she did. The Supreme Court, remember, is more conservative now.

Amarin is in a great position re: the generics after Friday's ruling. It was a game changer. What Markman and others fail to see is the biggest risk that generics face if they launch while this is still being decided in the courts. Those damages are in the billions in our case.

And best believe the generics saw the FAQ that came out this morning. I'm sure our lawyers already put them on notice. LOL They are on notice about launching.

You could cross a highway blindfolded and survive, but more than likely you are not going to try it because the risk of death is too great. That's where the generics are right now.

Thank Judge Pauline Newman.

https://www.ipwatchdog.com/2019/07/16/consider-courage-judge-newman-federal-circuit/id=111312/




Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News